Alzheimer’s blood test edges closer

For now, there is no definitive test for Alzheimer’s disease. Doctors rely on cognition tests and brain scans. So one of the main goals of Alzheimer’s research is to find ways of detecting the disease earlier.

A new technique published in the journal Genome Biology showed differences in the tiny fragments of genetic material floating in the blood could be used to identify the disease in patients. Early trials showed that the test was successfully “able to distinguish with high diagnostic accuracies between Alzheimer’s disease patients and healthy” people.

Read the full, original story here: Alzheimer’s blood test edges closer

Outbreak Daily Digest
Biotech Facts & Fallacies
Talking Biotech
Genetics Unzipped
Infographic: What are mRNA COVID-19 vaccines and how do they work?

Infographic: What are mRNA COVID-19 vaccines and how do they work?

As of 1 December 2020, thirteen vaccines have reached the final stage of testing: where they are being given to ...

Environmental Working Group: EWG challenges safety of GMOs, food pesticide residues

Known by some as the "Environmental Worrying Group," EWG lobbies ...
m hansen

Michael Hansen: Architect of Consumers Union ongoing anti-GMO campaign

Michael K. Hansen (born 1956) is thought by critics to be ...
News on human & agricultural genetics and biotechnology delivered to your inbox.
glp menu logo outlined

Newsletter Subscription

Optional. Mail on special occasions.
Send this to a friend